Miyamoto T, Katoh N
Laboratory of Biochemistry, National Institute of Animal Health, Ibaraki, Japan.
Am J Vet Res. 1997 Aug;58(8):811-5.
To determine: whether apolipoprotein A-I (apoA-I) is secreted by calf liver parenchymal cells; the isoprotein pattern and association with lipids of secreted apoA-I; and effects of steroid hormones on apoA-I secretion.
6 male Holstein calves (1 to 2 weeks old) as a cell culture source.
apoA-I in culture medium was detected by immunoblot analysis, and its concentration was measured by use of an ELISA. The isoprotein pattern was analyzed by use of two-dimensional polyacrylamide gel electrophoresis. Associations of apoA-I with cholesterol and phospholipids were examined by ultracentrifugal analysis of the culture medium.
Concentration of apoA-I in culture medium increased linearly up to 24 hours. The protein synthesis inhibitors, actinomycin D and cycloheximide, suppressed apoA-I accumulation in the medium in dose-dependent manner. Molecular mass of this protein in culture medium was 28 kd, and was indistinguishable from apoA-I of plasma. Four isoproteins with different isoelectric points (1 = 5.75; 2 = 5.67; 3 = 5.58; and 4 = 5.46) were detected. Of these, isoprotein 2 was the major species. By comparison, isoprotein 4 was the predominant species in plasma, and isoprotein 5 (isoelectric point = 5.38) was newly detected instead of isoprotein 1. Approximately 33% of apoA-I in culture medium was found in lipid-rich fractions, whereas the rest was found in nonlipoprotein fractions. Dexamethasone (10(-8) to 10(-6) M) significantly (P < 0.001) increased apoA-I concentration in the medium, and the stimulatory effect was significantly (P < 0.001) suppressed by the simultaneous addition of 10(-6) M progesterone. Progesterone itself (10(-8) to 10(-5) M) had little effect on apoA-I secretion; estradiol (10(-14) to 10(-8) M) also had no significant effect.
apoA-I is synthesized by calf liver parenchymal cells, and the secreted protein is modified during circulation. Moreover, apoA-I synthesis and secretion by the cells appear not to be largely influenced by hormones, except for dexamethasone.
确定:载脂蛋白A-I(apoA-I)是否由小牛肝实质细胞分泌;分泌的apoA-I的同工蛋白模式及其与脂质的关联;以及类固醇激素对apoA-I分泌的影响。
6头1至2周龄的雄性荷斯坦小牛作为细胞培养来源。
通过免疫印迹分析检测培养基中的apoA-I,并使用酶联免疫吸附测定法测量其浓度。通过二维聚丙烯酰胺凝胶电泳分析同工蛋白模式。通过对培养基进行超速离心分析来检测apoA-I与胆固醇和磷脂的关联。
培养基中apoA-I的浓度在24小时内呈线性增加。蛋白质合成抑制剂放线菌素D和环己酰亚胺以剂量依赖的方式抑制培养基中apoA-I的积累。培养基中这种蛋白质的分子量为28kd,与血浆中的apoA-I无法区分。检测到四种具有不同等电点的同工蛋白(1 = 5.75;2 = 5.67;3 = 5.58;4 = 5.46)。其中,同工蛋白2是主要类型。相比之下,同工蛋白4是血浆中的主要类型,并且新检测到了同工蛋白5(等电点 = 5.38),而不是同工蛋白1。培养基中约33%的apoA-I存在于富含脂质的组分中,其余的存在于非脂蛋白组分中。地塞米松(10^(-8)至10^(-6)M)显著(P < 0.001)增加培养基中apoA-I的浓度,并且同时添加10^(-6)M孕酮会显著(P < 0.001)抑制这种刺激作用。孕酮本身(10^(-8)至10^(-5)M)对apoA-I分泌几乎没有影响;雌二醇(10^(-14)至10^(-8)M)也没有显著影响。
apoA-I由小牛肝实质细胞合成,并且分泌的蛋白质在循环过程中会发生修饰。此外,除了地塞米松外,细胞合成和分泌apoA-I似乎在很大程度上不受激素影响。